Session Information
2013 Midyear Clinical Meeting
Click here to go to the previous page
Combination Antimicrobial Therapy and Optimal Beta-Lactam Administration: Pro / Con Debates in ID
Track:
New Practitioners Sessions (CE)
Program Code: 312-L01
Date: Sunday, December 8, 2013
Time: 1:00 PM to 3:00 PM EST
Location:
W311 F, Level 3
PRESENTER(S):
Meghan Jeffres
Christine Kubin, Pharm.D., Clinical Manager in Infectious Diseases
Simon Lam
Garrett Schramm
PROGRAM CHAIR:
Dr. Simon Lam, PharmD
- Describe the potential advantages associated with continuous or extended interval infusions of beta lactams.
- Identify patient groups which may benefit from single agent gram negative coverage.
- List the practical limitations associated with continuous or extended interval infusions of beta lactams.
- Summarize the clinical evidence in support for combination gram negative therapy.
This session is a part of: